Genetics, Vol 130, 163-173, Copyright © 1992

INVESTIGATIONS

Mitochondrial DNA Complex I and III Mutations Associated With Leber's Hereditary Optic Neuropathy

M. D. Brown, A. S. Voljavec, M. T. Lott, A. Torroni, C. C. Yang and D. C. Wallace
Center for Genetics and Molecular Medicine, Emory University School of Medicine, Atlanta, Georgia 30322

Four new missense mutations have been identified through restriction analysis and sequencing of the mitochondrial DNAs (mtDNA) from Leber's hereditary optic neuropathy (LHON) patients who lacked the previously identified 11778 mutation. Each altered a conserved amino acid and correlated with the LHON phenotype in population and phylogenetic analyses. The nucleotide pair (np) 13708 mutation (G to A, ND5 gene) changed an alanine to a threonine and was found in 6/25 (24%) of non-11778 LHON pedigrees and in 5.0% of controls, the np 15257 mutation (G to A, cytochrome b gene) changed an aspartate to an asparagine and was found in 4 of the 13708-positive pedigrees and 0.3% of controls, the np 15812 mutation (G to A, cytochrome b gene) changed a valine to a methionine and was detected in two of the 15257-positive pedigrees and 0.1% of controls and the np 5244 mutation (G to A, ND2 gene) changed a glycine to a serine and was found in one of the 15812-positive patients and none of 2103 controls. The 15257 mutation altered a highly conserved amino acid in an extramembrane domain of cytochrome b that is associated with the ligation of the low potential b(566) heme and the 5244 mutation altered a strongly evolutionarily conserved region of the ND2 polypeptide. The 13708 and 15812 mutations changed moderately conserved amino acids. Haplotype and phylogenetic analysis of the four np 15257 mtDNAs revealed that all harbored the same rare Caucasian haplotype and that the np 13708, np 15257, np 15812 and np 5244 mutations were added sequentially along this mtDNA lineage. Since the percentage of sighted controls decreases as these mutations accumulate, it appears that they interact synergistically, each increasing the probability of blindness. The involvement of both mitochondrial complex I (np 5244, 11778, 13708) and complex III (np 15257, 15812) mutations in LHON indicates that the clinical manifestations of this disease are the product of an overall decrease in mitochondrial energy production rather than a defect in a specific mitochondrial enzyme.

This article has been cited by other articles:

				L. Esser, M. Elberry, F. Zhou, C.-A. Yu, L. Yu, and D. Xia Inhibitor-complexed Structures of the Cytochrome bc1 from the Photosynthetic Bacterium Rhodobacter sphaeroides J. Biol. Chem., February 1, 2008; 283(5): 2846 - 2857. [Abstract] [Full Text] [PDF]

				E.C. Spikings, J. Alderson, and J.C.St. John Transmission of mitochondrial DNA following assisted reproduction and nuclear transfer Hum. Reprod. Update, July 1, 2006; 12(4): 401 - 415. [Abstract] [Full Text] [PDF]

				C Battisti, P Formichi, E Cardaioli, S Bianchi, P Mangiavacchi, S A Tripodi, P Tosi, and A Federico Cell response to oxidative stress induced apoptosis in patients with Leber's hereditary optic neuropathy J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1731 - 1736. [Abstract] [Full Text] [PDF]

				B. R. Gauthier, T. Brun, E. J. Sarret, H. Ishihara, O. Schaad, P. Descombes, and C. B. Wollheim Oligonucleotide Microarray Analysis Reveals PDX1 as an Essential Regulator of Mitochondrial Metabolism in Rat Islets J. Biol. Chem., July 23, 2004; 279(30): 31121 - 31130. [Abstract] [Full Text] [PDF]

				R. G. Blazej, B. M. Paegel, and R. A. Mathies Polymorphism Ratio Sequencing: A New Approach for Single Nucleotide Polymorphism Discovery and Genotyping Genome Res., February 1, 2003; 13(2): 287 - 293. [Abstract] [Full Text] [PDF]

				R. Lodi, P. Montagna, P. Cortelli, S. Iotti, S. Cevoli, V. Carelli, and B. Barbiroli `Secondary' 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation Brain, September 1, 2000; 123(9): 1896 - 1902. [Abstract] [Full Text] [PDF]

				D. Jarreta, J. Orus, A. Barrientos, O. Miro, E. Roig, M. Heras, C. T Moraes, F. Cardellach, and J. Casademont Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy Cardiovasc Res, March 1, 2000; 45(4): 860 - 865. [Abstract] [Full Text] [PDF]

				P. Awadalla, A. Eyre-Walker, and J. M. Smith Linkage Disequilibrium and Recombination in Hominid Mitochondrial DNA Science, December 24, 1999; 286(5449): 2524 - 2525. [Abstract] [Full Text]

				D. K. Simon, S. M. Pulst, J. P. Sutton, S. E. Browne, M. F. Beal, and D. R. Johns Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation Neurology, November 1, 1999; 53(8): 1787 - 1787. [Abstract] [Full Text] [PDF]

				G. Hofhaus, D. R. Johns, O. Hurko, G. Attardi, and A. Chomyn Respiration and Growth Defects in Transmitochondrial Cell Lines Carrying the 11778 Mutation Associated with Leber's Hereditary Optic Neuropathy J. Biol. Chem., May 31, 1996; 271(22): 13155 - 13161. [Abstract] [Full Text] [PDF]

				D. Wallace Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science, May 1, 1992; 256(5057): 628 - 632. [Abstract] [PDF]